Literature DB >> 1711157

The B-cell surface protein CD72/Lyb-2 is the ligand for CD5.

H Van de Velde1, I von Hoegen, W Luo, J R Parnes, K Thielemans.   

Abstract

The glycoprotein CD5 is expressed on the surface membrane of all mature T cells and a small proportion of B lymphocytes. Its exact role in immune interactions is still unknown. Studies indicate that CD5 functions both in mice and humans as a receptor, delivering co-stimulatory signals to T cells in a manner similar to CD2 (ref. 11) and CD28 (ref. 12). Anti-CD5 antibodies stimulate both T-cell proliferation mediated by CD3 in association with the T-cell receptor and secretion of interleukin-2 and expression of its receptor, as well as inducing an increase in intracellular Ca2+ concentration (refs 5-10). To identify the ligand for CD5 we purified the human CD5 protein, labelled it with biotin and used it as a probe. Here we report that CD5 specifically interacts with the cell-surface protein CD72 exclusive to B cells. This interaction is blocked by anti-CD72 antibodies, but not by any other anti-B-cell antibodies. Moreover, non-B cells (mouse L-cell fibroblasts and human Jurkat T cells) expressing a transfected human CD72 complementary DNA could bind to the CD5-biotin conjugate. The results demonstrate that the B-cell surface protein CD72 (Lyb-2 in mice) is the ligand for CD5.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1711157     DOI: 10.1038/351662a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  69 in total

1.  CD5 negatively regulates the T-cell antigen receptor signal transduction pathway: involvement of SH2-containing phosphotyrosine phosphatase SHP-1.

Authors:  J J Perez-Villar; G S Whitney; M A Bowen; D H Hewgill; A A Aruffo; S B Kanner
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

Review 2.  Positive and negative roles of CD72 in B cell function.

Authors:  Hsin-Jung Wu; Subbarao Bondada
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

Review 3.  CD5, an important regulator of lymphocyte selection and immune tolerance.

Authors:  Chander Raman
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

4.  Molecular cloning, genomic organization and cell-binding characteristics of mouse Spalpha.

Authors:  J A Gebe; M Llewellyn; H Hoggatt; A Aruffo
Journal:  Immunology       Date:  2000-01       Impact factor: 7.397

5.  DBA/2J (Mls-1a) B-cell differentiation in BALB.xid recipients.

Authors:  K Tocce; K Suppiah; C Rago; R Liberchuk; K Duffy; J Riggs
Journal:  Immunology       Date:  2000-01       Impact factor: 7.397

6.  Molecular associations between the T-lymphocyte antigen receptor complex and the surface antigens CD2, CD4, or CD8 and CD5.

Authors:  A D Beyers; L L Spruyt; A F Williams
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

7.  CD22-mediated stimulation of T cells regulates T-cell receptor/CD3-induced signaling.

Authors:  A Aruffo; S B Kanner; D Sgroi; J A Ledbetter; I Stamenkovic
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

8.  Differentiation between MHC-restricted and non-MHC-restricted porcine cytolytic T lymphocytes.

Authors:  T Pauly; E Weiland; W Hirt; C Dreyer-Bux; S Maurer; A Summerfield; A Saalmüller
Journal:  Immunology       Date:  1996-06       Impact factor: 7.397

Review 9.  The role of semaphorins in immune responses and autoimmune rheumatic diseases.

Authors:  Masayuki Nishide; Atsushi Kumanogoh
Journal:  Nat Rev Rheumatol       Date:  2017-12-07       Impact factor: 20.543

10.  Expression of CD5 and CD72 on T and B cell subsets in rheumatoid arthritis and Sjögren's syndrome.

Authors:  C Jamin; A Lamour; Y L Pennec; M Hirn; P Le Goff; P Youinou
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.